Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine

Eitemau Tebyg

• Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission
  gan: Lehman, Dara A., et al.
  Cyhoeddwyd: (2009)
• Independent Effects of Nevirapine Prophylaxis and HIV-1 RNA Suppression in Breast Milk on Early Perinatal HIV-1 Transmission
  gan: Chung, Michael H., et al.
  Cyhoeddwyd: (2007)
• Highly Active Antiretroviral Therapy (HAART) versus Zidovudine/Nevirapine Effects on Early Breast Milk HIV-1 RNA: A Phase II Randomized Clinical Trial
  gan: Chung, Michael H., et al.
  Cyhoeddwyd: (2008)
• HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission
  gan: Lehman, Dara A., et al.
  Cyhoeddwyd: (2008)
• Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels
  gan: Slyker, Jennifer A., et al.
  Cyhoeddwyd: (2017)